Healthcare Adapts to “New Normal” with Ariba

Supply market volatility. Capacity constraints. Global uncertainty. They are the reality of doing business in the New Normal that all companies must deal with. Add to this, calls for reform, regulatory uncertainty, competition from generic drugs, shrinking R&D pipelines and declining demand for elective procedures, and the reality becomes even more complex for healthcare concerns.

On May 25, executives from providers, producers, payers, and distributors will discuss these challenges and ways in which they can collaborate to overcome them during a Townhall Meeting at Ariba Live, a conference for anyone engaged in buying, selling or managing cash, hosted by Ariba.

"The future of healthcare has never been more uncertain," said Mike Dunn, director, Healthcare Accounts, Ariba. "From reform proposals and expiring patents to tight budgets and fewer resources, healthcare organizations face an unprecedented set of challenges that will require them to think and operate in different ways to overcome."

During the meeting, companies across the healthcare industry will outline their challenges and explore ways in which they can leverage new solutions and processes to optimize their performance and enhance the results that they deliver.